Essity's 2024 Annual General Meeting concludes with approval for the parent company income statement, balance sheet and consolidated income statement and consolidated balance sheet for 2023; board announces dividend of SEK 7.75/share for 2023 fiscal year

Sample article from our Tissue & Hygiene

March 21, 2024 (press release) –

Essity today held the Annual General Meeting at Stockholm Waterfront Congress Centre, Sweden. 

The Meeting approved the Parent Company income statement and balance sheet and the consolidated income statement and consolidated balance sheet for 2023.

The Meeting resolved in accordance with the Board of Director’s proposal and decided on a dividend of SEK 7.75 per share for the 2023 fiscal year. Record date for the dividend is set to Monday, March 25, 2024. The dividend is scheduled to be distributed by Euroclear Sweden AB on Thursday, March 28, 2024.

The Meeting resolved that the remuneration to each director elected by the Annual General Meeting who is not employed by the company shall amount to SEK 910,000 and the Chairman of the Board of Directors is to receive SEK 2,730,000. Members of the Remuneration Committee are each to receive an additional remuneration of  SEK 135,000, while the Chairman of the Remuneration Committee is to receive an additional remuneration of SEK 160,000. Members of the Audit Committee are each to receive an additional remuneration of SEK 320,000, while the Chairman of the Audit Committee is to receive an additional remuneration of SEK 450,000. Members of the Portfolio Development Committee are each to receive an additional remuneration of SEK 310,000, while the Chairman of the Portfolio Development Committee is to receive an additional remuneration of SEK 435,000. Remuneration to the auditor is to be paid according to approved invoice.

The Annual General Meeting resolved in accordance with the Board of Director’s proposal on guidelines for remuneration of senior executives and a cash-based incentive program. The meeting also approved the Board of Director’s remuneration report. The Board of Directors and the CEO were granted discharge from liability for the 2023 fiscal year.

Board members Ewa Björling, Maria Carell, Annemarie Gardshol, Magnus Groth, Jan Gurander, Torbjörn Lööf, Bert Nordberg and Barbara Milian Thoralfsson were re-elected.  Karl Åberg was elected as a new director. Pär Boman had declined re-election. Jan Gurander was elected Chairman of the Board. Ernst & Young AB was appointed the company’s auditor for a mandate period until the end of the 2025 Annual General Meeting.

The Annual General Meeting authorized the Board of Directors to decide on buy-back of Essity B shares and to transfer shares bought back by the company. These authorizations are valid until the next Annual General Meeting.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.